Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Meadowsweet flower contains up to 65 mg/g of phenolic compounds, with salicylates providing COX-2 and iNOS enzyme inhibition for anti-inflammatory effects. The unique flavonoid ulmarioside and quercetin derivatives suppress T-cell proliferation and reduce reactive oxygen species production.
Reported Benefits (Provisional)
Origin & History
Meadowsweet (*Filipendula ulmaria*) is a perennial herb native to Europe, Asia, and North America, thriving in damp meadows and wetlands. Its fragrant white flowers have been historically valued for their medicinal properties. In functional nutrition, Meadowsweet is recognized for its anti-inflammatory compounds and digestive support.
Research Narrative (Provisional)
Modern research, including in vitro and animal studies, supports Meadowsweet's anti-inflammatory, analgesic, and gastroprotective properties, largely attributed to its salicylate and flavonoid content. Studies also indicate its potential for cardiovascular and immune support. Further human clinical trials are warranted to confirm these effects.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Salicylates, Tannins, Flavonoids, Polyphenols, Catechins
Reported Mechanism (Provisional)
Meadowsweet's salicylic acid derivatives inhibit cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression, reducing inflammatory mediator production. Ethyl acetate extracts containing quercetin and ulmarioside suppress T-cell proliferation and complement cascade activation. The catechin compounds regulate gene expression of inflammatory cytokines while the salicylaldehyde and methyl salicylate in volatile oils provide direct analgesic effects.
Clinical Narrative (Provisional)
Clinical evidence for meadowsweet flower remains limited, with only one identified human study showing effectiveness in cervical dysplasia treatment when formulated as a topical ointment. The majority of supporting evidence comes from in vitro laboratory studies demonstrating anti-inflammatory and antioxidant properties of isolated polyphenolic compounds. Animal studies support gastroprotective and analgesic effects, but robust randomized controlled trials with quantified outcomes in humans are lacking. Current therapeutic applications rely primarily on traditional use patterns rather than clinical validation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.